Peripheral Drug Eluting Balloons Market Insights, Competitive Landscape, and Market Forecast

Description

The global Peripheral Drug Eluting Balloons (DEB) market is witnessing consistent growth, driven by the increasing prevalence of vascular disorders and the growing demand for minimally invasive treatment procedures. Drug eluting balloons are widely used in angioplasty to treat blocked or narrowed peripheral arteries by delivering therapeutic drugs directly to the affected area. These devices help reduce restenosis rates while eliminating the need for permanent implants, making them a preferred solution in modern vascular interventions.

Market Insights

The Peripheral Drug Eluting Balloons market is estimated to reach USD 1.2 billion in 2026 and is projected to grow to USD 2.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.30% during the forecast period. This growth is primarily attributed to the rising burden of peripheral arterial disease (PAD), increasing awareness regarding early diagnosis, and continuous technological advancements in balloon catheter systems.

The ability of drug eluting balloons to deliver localized drug therapy while minimizing long-term complications has significantly enhanced their adoption across hospitals and specialized care centers. Additionally, the shift toward outpatient procedures is further contributing to market expansion.

Market Drivers

The growth of the Peripheral Drug Eluting Balloons market is supported by several key factors:

Increasing prevalence of peripheral arterial disease and related vascular conditions
Growing aging population susceptible to chronic vascular disorders
Rising preference for minimally invasive procedures with shorter recovery times
Continuous advancements in drug coating technologies, including paclitaxel and sirolimus
Expansion of healthcare infrastructure in developing economies

Moreover, the increasing number of cardiac catheterization laboratories and ambulatory surgical centers is enabling greater access to advanced interventional treatments.

Business Opportunity

The market presents strong growth opportunities, particularly in emerging economies where healthcare systems are rapidly evolving. Countries in Asia Pacific and Latin America are investing significantly in healthcare infrastructure, creating a favorable environment for the adoption of advanced medical devices.

Ongoing research and development efforts aimed at improving drug delivery efficiency and enhancing patient outcomes are expected to drive innovation in this space. The development of next-generation drug eluting balloons with improved safety profiles and longer-lasting effects is likely to attract significant investments.

In addition, strategic initiatives such as partnerships, collaborations, and acquisitions among key players are expected to strengthen market positioning and expand product portfolios.

Region Analysis

North America dominates the Peripheral Drug Eluting Balloons market due to its advanced healthcare infrastructure, high adoption rate of innovative technologies, and strong presence of leading market players. Favorable reimbursement policies further support market growth in this region.

Europe holds a significant share, driven by increasing healthcare expenditure and a strong focus on minimally invasive treatment approaches. Countries such as Germany, the United Kingdom, and France are key contributors to regional growth.

The Asia Pacific region is anticipated to experience the fastest growth during the forecast period. Factors such as a large patient population, rising healthcare investments, and increasing awareness of advanced treatment options are driving market expansion in countries like China, India, and Japan.

Latin America and the Middle East & Africa are also witnessing gradual growth, supported by improving healthcare access and rising awareness about vascular disease management.

Key Players

The market is highly competitive, with several global and regional players contributing to its growth. Key companies include:

Abbott Laboratories
Boston Scientific Corporation
Cook Medical Inc.
MicroPort Scientific Corporation (Endovastec(TM))
Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Kyoto Medical Planning Co Ltd
iVascular S.L.U
AMG International GmbH
ENDOCOR GmbH
Meril Life Sciences Pvt. Ltd.
Nano Therapeutics Pvt Ltd
Koninklijke Philips N.V.
REVA Medical

These companies are focusing on product innovation, technological advancements, and geographic expansion to strengthen their market presence.

Conclusion

The Peripheral Drug Eluting Balloons market is expected to witness substantial growth over the coming years, supported by the increasing incidence of vascular diseases and the growing preference for minimally invasive treatment solutions. With continuous technological progress and expanding healthcare access, drug eluting balloons are set to play a crucial role in improving patient outcomes in vascular care.

Market Segmentation

Drug Coating:

Paclitaxel Drug Coating
Sirolimus Drug Coating
Others

Indication:

Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others

Artery Type:

Carotid Arteries
Fem-Pop Arteries
Iliac Arteries
Infrapop Arteries

End User:

Hospitals
Ambulatory Surgical Centres/Outpatients
Cardiac Catheterization Labs

Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1. Executive Summary

1.1. Global Peripheral Drug Eluting Balloons Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors

3. Global Peripheral Drug Eluting Balloons Market Outlook, 2020-2033

3.1. Global Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn), 2020-2033
- 3.1.1. Paclitaxel Drug Coating
- 3.1.2. Sirolimus drug Coating
- 3.1.3. Others
3.2. Global Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 3.2.1. Peripheral Arterial Disease
- 3.2.2. Peripheral Aneurysms
- 3.2.3. In-Stent Restenosis
- 3.2.4. Others
3.3. Global Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn), 2020-2033
- 3.3.1. Carotid Arteries
- 3.3.2. Fem-Pop Arteries
- 3.3.3. Iliac Arteries
- 3.3.4. Infrapop Arteries
3.4. Global Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Hospitals
- 3.4.2. Ambulatory Surgical Centres/Outpatients
- 3.4.3. Cardiac Catheterization Labs
3.5. Global Peripheral Drug Eluting Balloons Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa

4. North America Peripheral Drug Eluting Balloons Market Outlook, 2020-2033

4.1. North America Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn), 2020-2033
- 4.1.1. Paclitaxel Drug Coating
- 4.1.2. Sirolimus drug Coating
- 4.1.3. Others
4.2. North America Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 4.2.1. Peripheral Arterial Disease
- 4.2.2. Peripheral Aneurysms
- 4.2.3. In-Stent Restenosis
- 4.2.4. Others
4.3. North America Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn), 2020-2033
- 4.3.1. Carotid Arteries
- 4.3.2. Fem-Pop Arteries
- 4.3.3. Iliac Arteries
- 4.3.4. Infrapop Arteries
4.4. North America Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Hospitals
- 4.4.2. Ambulatory Surgical Centres/Outpatients
- 4.4.3. Cardiac Catheterization Labs
4.5. North America Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 4.5.2. U.S. Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 4.5.3. U.S. Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 4.5.4. U.S. Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 4.5.6. Canada Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 4.5.7. Canada Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 4.5.8. Canada Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Peripheral Drug Eluting Balloons Market Outlook, 2020-2033

5.1. Europe Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn), 2020-2033
- 5.1.1. Paclitaxel Drug Coating
- 5.1.2. Sirolimus drug Coating
- 5.1.3. Others
5.2. Europe Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 5.2.1. Peripheral Arterial Disease
- 5.2.2. Peripheral Aneurysms
- 5.2.3. In-Stent Restenosis
- 5.2.4. Others
5.3. Europe Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn), 2020-2033
- 5.3.1. Carotid Arteries
- 5.3.2. Fem-Pop Arteries
- 5.3.3. Iliac Arteries
- 5.3.4. Infrapop Arteries
5.4. Europe Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Hospitals
- 5.4.2. Ambulatory Surgical Centres/Outpatients
- 5.4.3. Cardiac Catheterization Labs
5.5. Europe Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.2. Germany Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.3. Germany Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.4. Germany Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.6. Italy Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.7. Italy Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.8. Italy Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 5.5.9. France Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.10. France Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.11. France Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.12. France Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.14. U.K. Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.15. U.K. Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.16. U.K. Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.18. Spain Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.19. Spain Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.20. Spain Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.22. Russia Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.23. Russia Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.24. Russia Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 5.5.26. Rest of Europe Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 5.5.27. Rest of Europe Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 5.5.28. Rest of Europe Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, 2020-2033

6.1. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn), 2020-2033
- 6.1.1. Paclitaxel Drug Coating
- 6.1.2. Sirolimus drug Coating
- 6.1.3. Others
6.2. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 6.2.1. Peripheral Arterial Disease
- 6.2.2. Peripheral Aneurysms
- 6.2.3. In-Stent Restenosis
- 6.2.4. Others
6.3. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn), 2020-2033
- 6.3.1. Carotid Arteries
- 6.3.2. Fem-Pop Arteries
- 6.3.3. Iliac Arteries
- 6.3.4. Infrapop Arteries
6.4. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Hospitals
- 6.4.2. Ambulatory Surgical Centres/Outpatients
- 6.4.3. Cardiac Catheterization Labs
6.5. Asia Pacific Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 6.5.2. China Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 6.5.3. China Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 6.5.4. China Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 6.5.6. Japan Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 6.5.7. Japan Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 6.5.8. Japan Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 6.5.10. South Korea Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 6.5.11. South Korea Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 6.5.12. South Korea Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 6.5.13. India Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 6.5.14. India Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 6.5.15. India Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 6.5.16. India Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 6.5.18. Southeast Asia Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 6.5.19. Southeast Asia Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 6.5.20. Southeast Asia Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 6.5.22. Rest of SAO Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 6.5.23. Rest of SAO Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 6.5.24. Rest of SAO Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Peripheral Drug Eluting Balloons Market Outlook, 2020-2033

7.1. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn), 2020-2033
- 7.1.1. Paclitaxel Drug Coating
- 7.1.2. Sirolimus drug Coating
- 7.1.3. Others
7.2. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 7.2.1. Peripheral Arterial Disease
- 7.2.2. Peripheral Aneurysms
- 7.2.3. In-Stent Restenosis
- 7.2.4. Others
7.3. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn), 2020-2033
- 7.3.1. Carotid Arteries
- 7.3.2. Fem-Pop Arteries
- 7.3.3. Iliac Arteries
- 7.3.4. Infrapop Arteries
7.4. Latin America Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgical Centres/Outpatients
- 7.4.3. Cardiac Catheterization Labs
7.5. Latin America Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 7.5.2. Brazil Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 7.5.3. Brazil Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 7.5.4. Brazil Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 7.5.6. Mexico Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 7.5.7. Mexico Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 7.5.8. Mexico Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 7.5.10. Argentina Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 7.5.11. Argentina Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 7.5.12. Argentina Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 7.5.14. Rest of LATAM Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 7.5.15. Rest of LATAM Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 7.5.16. Rest of LATAM Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, 2020-2033

8.1. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, Value (US$ Bn), 2020-2033
- 8.1.1. Paclitaxel Drug Coating
- 8.1.2. Sirolimus drug Coating
- 8.1.3. Others
8.2. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Indication, Value (US$ Bn), 2020-2033
- 8.2.1. Peripheral Arterial Disease
- 8.2.2. Peripheral Aneurysms
- 8.2.3. In-Stent Restenosis
- 8.2.4. Others
8.3. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, Value (US$ Bn), 2020-2033
- 8.3.1. Carotid Arteries
- 8.3.2. Fem-Pop Arteries
- 8.3.3. Iliac Arteries
- 8.3.4. Infrapop Arteries
8.4. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Hospitals
- 8.4.2. Ambulatory Surgical Centres/Outpatients
- 8.4.3. Cardiac Catheterization Labs
8.5. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 8.5.2. GCC Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 8.5.3. GCC Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 8.5.4. GCC Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 8.5.6. South Africa Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 8.5.7. South Africa Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 8.5.8. South Africa Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 8.5.10. Egypt Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 8.5.11. Egypt Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 8.5.12. Egypt Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 8.5.14. Nigeria Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 8.5.15. Nigeria Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 8.5.16. Nigeria Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Peripheral Drug Eluting Balloons Market Outlook, by Drug Coating, 2020-2033
- 8.5.18. Rest of Middle East Peripheral Drug Eluting Balloons Market Outlook, by Indication, 2020-2033
- 8.5.19. Rest of Middle East Peripheral Drug Eluting Balloons Market Outlook, by Artery Type, 2020-2033
- 8.5.20. Rest of Middle East Peripheral Drug Eluting Balloons Market Outlook, by End User, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Abbott Laboratories
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Developments
- 9.4.2. Boston Scientific Corporation
- 9.4.3. Cook Medical Inc.
- 9.4.4. MicroPort Scientific Corporation (Endovastec(TM))
- 9.4.5. Medtronic Plc.
- 9.4.6. Cardinal Health, Inc.
- 9.4.7. B. Braun Melsungen AG
- 9.4.8. BIOTRONIK SE & Co. KG
- 9.4.9. Becton, Dickinson and Company
- 9.4.10. W. L. Gore & Associates Inc.

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Peripheral Drug Eluting Balloons Market Insights, Competitive Landscape, and Market Forecast - 2033